Infectious Diseases

Eur Rev Med Pharmacol Sci 2020; 24 (17): 9208-9215
DOI: 10.26355/eurrev_202009_22873

Advances in SARS-CoV-2: a systematic review

Y.-X. Bai, Y.-H. Xu, X. Wang, C. Sun, Y. Guo, S. Qiu, K.-W. Ma
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (17): 9202-9207
DOI: 10.26355/eurrev_202009_22872

SARS-CoV-2 RNA contamination on surfaces of a COVID-19 ward in a hospital of Northern Italy: what risk of transmission?

M. D’accolti, I. Soffritti, A. Passaro, G. Zuliani, P. Antonioli, S. Mazzacane, R. Manfredini, E. Caselli
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (17): 9196-9201
DOI: 10.26355/eurrev_202009_22871

Pathogenic analysis of suspected COVID-19 patients in a SARS-CoV-2 non-epidemic area of China

Y.-H. Ji, T. Qi, Y. Ding, Q. Ruan, Y.-P. Ma
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (17): 9188-9195
DOI: 10.26355/eurrev_202009_22870

A contemporary look at COVID-19 medications: available and potentially effective drugs

H.K. Alshaeri, Z.S. Natto
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (17): 9182-9187
DOI: 10.26355/eurrev_202009_22869

Nutraceuticals as immune-stimulating therapy to fight COVID-19. Combination of elements to improve the efficacy

A. Di Stadio, R. Ishai, V. Gambacorta, F. Korsch, G. Ricci, A. della Volpe, E. Bernitsas
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (17): 9172-9181
DOI: 10.26355/eurrev_202009_22868

An association between exposure to Middle East Respiratory Syndrome (MERS) and mortality rate of Coronavirus Disease 2019 (COVID-19)

U. Naeem, A. Naeem, M.A. Naeem, K. Naeem, B. Mujtaba, A. Mujtaba, A. Khurshid
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (17): 9169-9171
DOI: 10.26355/eurrev_202009_22867

SARS-CoV-2 infection: NLRP3 inflammasome as plausible target to prevent cardiopulmonary complications?

V. Quagliariello, A. Bonelli, A. Caronna, M.C. Lombari, G. Conforti, M. Libutti, R.V. Iaffaioli, M. Berretta, G. Botti, N. Maurea
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (17): 9161-9168
DOI: 10.26355/eurrev_202009_22866

Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications

S. Voicu, M. Delrue, B.G. Chousterman, A. Stépanian, P. Bonnin, I. Malissin, N. Deye, M. Neuwirth, C. Ketfi, A. Mebazaa, V. Siguret, B. Mégarbane
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (17): 9154-9160
DOI: 10.26355/eurrev_202009_22864

Venous thromboembolism in critically ill patients affected by ARDS related to COVID-19 in Northern-West Italy

Y. Longhitano, F. Racca, C. Zanza, A. Piccioni, A. Audo, M. Muncinelli, R. Santi, D. Kozel, C. Geraci, M. Taverna, V. Bonato, F. Cassini, F. Franceschi
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (17): 9151-9153
DOI: 10.26355/eurrev_202009_22863

Short report – Herpes simplex lesion in the lip semimucosa in a COVID-19 patient

D. Kitakawa, F.E. Oliveira, P. Neves de Castro, L.F.C.S. Carvalho
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (17): 8632-8634
DOI: 10.26355/eurrev_202009_22799

Lung ultrasound signs and cytokine profile in Covid-19 patients: a case series

S. Delrio, L. Vetrugno, D. Orso, C. Deana, N. D’Andrea, T. Bove
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (16): 8606-8620
DOI: 10.26355/eurrev_202008_22660

Three critical clinicobiological phases of the human SARS-associated coronavirus infections

C. Turk, S. Turk, U.Y. Malkan, I.C. Haznedaroglu
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (16): 8592-8605
DOI: 10.26355/eurrev_202008_22659

Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review

M. Vargas, G. Servillo, S. Einav
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (16): 8585-8591
DOI: 10.26355/eurrev_202008_22658

Prospects for the use of regulators of oxidative stress in the comprehensive treatment of the novel Coronavirus Disease 2019 (COVID-19) and its complications

G.D. Mironova, N.V. Belosludtseva, M.A. Ananyan
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (16): 8583-8584
DOI: 10.26355/eurrev_202008_22657

Measures to prevent goggles from fogging during the treatment of Coronavirus Disease 2019

Y.-L. Ding, Z.-Q. Gu, Y. Liu, J.-L. Niu
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (16): 8580-8582
DOI: 10.26355/eurrev_202008_22656

The effects of COVID-19 pandemic on elective post-bariatric surgery waiting list: a single Plastic Surgery Center investigation

G. Marruzzo, U. Redi, L. Patanè, E. Cavalieri, J.M. Frattaroli, G. D’Ermo, F. Lo Torto, S. Carella, F.R. Grippaudo, D. Ribuffo
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (16): 8576-8579
DOI: 10.26355/eurrev_202008_22655

D-dimer is associated with the risk of mortality in Coronavirus Disease 2019 patients

L. Shi, Y. Wang, Y.-D. Wang, G.-C. Duan, H.-Y. Yang
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (16): 8573-8575
DOI: 10.26355/eurrev_202008_22653

Will a tumor pandemic come after the COVID-19 pandemic? Head and Neck cancer perspective

G. Mannelli, R. Santoro, P. Bonomo, I. Desideri, G. Spinelli
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (15): 8232-8238
DOI: 10.26355/eurrev_202008_22513

Climate and COVID-19 pandemic: effect of heat and humidity on the incidence and mortality in world’s top ten hottest and top ten coldest countries

S.A. Meo, A.A. Abukhalaf, A.A. Alomar, I.Z. Al-Beeshi, A. Alhowikan, K.M. Shafi, A.S. Meo, A.M. Usmani, J. Akram
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (15): 8226-8231
DOI: 10.26355/eurrev_202008_22512

Association between the spread of COVID-19 and weather-climatic parameters

M.G. Carta, A. Scano, J. Lindert, S. Bonanno, L. Rinaldi, S. Fais, G. Orrù
Free PDF Download